Term
History of Sulfa Drugs
(8) |
|
Definition
- PRONTOSIL (azo dye) -- 1930 -- I. G. Farbenindustrie This company also made
- ZyklonB for Hitler’s extermination camps
- Domagk = research manager
- tested antimicrobial potential in vitro & in vivo
- determined that a sulfonamide (sulfonilamide) was the active portion of molecule.
- awarded a Nobel Prize in Medicine in 1938
- Foerster – 1933 - first clinical study – 10 month old infant with staph septicemia
- The 1st effective chemotherapeutic agent
|
|
|
Term
Overview of Sulfa Drugs
(2) |
|
Definition
- Single sulfonamides:
- *Trimethoprim-sulfamethoxazole (TMP-SMX)
|
|
|
Term
Overview of Sulfa
Drugs Single sulfonamides:
(7) |
|
Definition
- Once the mainstay of chemotherapy but *now less used in US because resistance is increasing.
- *Still commonly used in under-developed countries because they are cheap & readily available.
- *Effective against
- many bacteria,
- several parasites and
- one fungus
- but ineffective against viruses.
|
|
|
Term
Overview of Sulfa Drugs
*Trimethoprim-sulfamethoxazole (TMP-SMX)
(4) |
|
Definition
- combo
- Synergistic Very frequently used
|
|
|
Term
Structure of Sulfonamides Picture
Structure of Sulfonamides
(4) |
|
Definition
- All sulfa drugs are chemical congeners of PABA.
- *All Sulfas have S-C bond and p-NH2
- *5000 synthesized, 150 marketed!
- *Pathogens are only susceptible if they require PABA to synthesize folic acid.
|
|
|
Term
Structure of Sulfonamides
*5000 synthesized, 150 marketed!
(5) |
|
Definition
- An example of molecular roulette
- This pioneering work also lead to development of
- sulfonylurea hypoglycemic agents,
- inhibitors of carbonic anhydrase,
- & phenazopyridine
|
|
|
Term
MOA of the Sulfonamides
(4) |
|
Definition
- *Most are competitive inhibitors of DHPS…
- But some inhibit indirectly by serving as an *alternative substrate & exhausting the pteridine cofactor.
- Single sulfas are generally regarded as *bacteriostatic as they prevent new DNA synthesis.
- *Sulfas are selective for bugs because people use dietary folate
|
|
|
Term
MOA of the Sulfonamides Picture Development of Resistance to Sulfonamides (4) |
|
Definition
|
|
Term
Development of Resistance to Sulfonamides
(4) |
|
Definition
- Can reduce drug uptake or speed its efflux (small multidrug resistance family [SMR])
- Can alter drug binding site on DHPS; this can occur even during therapy
- Can cause overproduction of PABA which is competitive with drug at the active site
- Can cause development of an alternative path for folate synthesis
|
|
|
Term
Therapeutic Uses Of Single Sulfa Drugs In General (5) |
|
Definition
- *They were widely used in the past for UTIs because:
- *Most drug is excreted in active form & concentrated 10-20x in urine which might be bactericidal for some bugs even if not normally recommended at other sites.
- *But single sulfa drugs are now rarely used for UTIs because:
- Increased resistance among enteric gram (-) bacilli which most frequently cause UTIs.
- Better agents are now available (TMP-SMX, a fluoroquinolone, fosfomycin, ampicillin
|
|
|
Term
Therapeutic Uses Of Single Sulfa Drugs In General Single Species
(6) |
|
Definition
- *In terms of species, single sulfas are backup drugs for
- Mycobacterium fortuitum,
- Chlamydia trachomatis,
- Neisseria meningitides,
- & Nocardia†
- († but TMP-SMX is now the drug of choice).
|
|
|
Term
Specific Therapeutic Uses Of Individual Sulfonamides SULFISOXAZOLE (GANTRISIN): ORAL General (3) |
|
Definition
- The individual sulfonamides are rarely drugs of first choice with the exceptions cited below.
|
|
|
Term
SULFISOXAZOLE (GANTRISIN):
ORAL Uses:
(7) |
|
Definition
- *Used for Rx of uncomplicated UTIs
- *Alternate for:
- Chlamydia,
- Mycobacterium fortuitum,
- Nocardia,
- Neisseria meningitidis
- *Ineffective for CNS infections because of its low lipid solubility
|
|
|
Term
SULFAMETHOXAZOLE (GANTANOL): ORAL
(5) |
|
Definition
- *Similar to sulfisoxazole but:
- It is more slowly absorbed and excreted
- *It has a longer t½ (11 hr)
- *It is more likely to cause crystalluria
- *Reminder: It is usually marketed with trimethoprim in TMP-SMX
|
|
|
Term
|
Definition
- *Achieves highest concentration in CSF (30-80% of [plasma])
- Relatively rapidly absorbed & excreted
- *Its use is limited by crystalluria!!!
- *Urine flow must be brisk (>1.2 L/day in adults)
- *Bicarbonate reduces renal tubular reabsorption and thereby accelerates renal clearance.
|
|
|
Term
SULFASALAZINE (AZULFIDINE):
(8) |
|
Definition
- POORLY ABSORBED ORAL DRUG
- *One of top 300 drugs
- *Mostly held in GI tract/bowel & excreted in feces
- *Used for inflammatory bowel disease (IBD), ulcerative colitis, regional enteritis bec. of antiinflammatory properties.
- It is a *prodrug Sulfasalazine ▬► Sulfapyridine + 5-aminosalicylate (5AS)
- *5AS (mesalamine) is an active antiinflammatory compound that inhibits cyclooxygenase
- *A comparable concentration of mesalamine in the colon cannot otherwise be obtained.
- *Sulfapyridine can cause systemic toxic effects
|
|
|
Term
SILVER SULFADIAZINE (SILVADENE):
(6) |
|
Definition
- TOPICAL
- *Agent of choice for prevention of infections in 2nd & 3rd degree burns
- *Silver released is a broad-spectrum agent x bacteria and fungi.
- *It reduces colonization, prevents sepsis, & encourages healing but is *not useful against established deep infections.
- *It is used topically on burns with little toxicity.
- *Systemic absorption is possible when applied to a large area.
|
|
|
Term
SULFACETAMIDE (SULAMYD)
(5) |
|
Definition
- A topical opthalmic
- *It is used for Rx of many sulfonamide- sensitive ophthalmic infections.
- *It is an impt. alternate for Chlamydia trachomatis.
- *High concentrations (30%) aren’t irritating or allergenic & are of neutral pH
- *It readily penetrates ocular fluids and tissues.
|
|
|
Term
Pharmacokinetics Of Sulfonamides
(5) |
|
Definition
- *Most are well absorbed orally (70-95%)
- *Most are widely distributed including into the CSF, fetus (but sulfadiazine best for CSF)
- *Acetylation occuring in liver inactivates & decreases solubility which increases crystallization.
- *Elimination is by glomerular filtration so renal function is required.
|
|
|
Term
|
Definition
- *Crystals of sulfonamide & acetylated sulfonamide can cause renal damage [Least common with sulfisoxazole.]
- *Most common with sulfadoxine used for prophylaxis of malaria with pyrimethamine (Remember fluids, bicarbonate!)
- *Must use reduced dosage (or cease use) if kidney function is impaired.
|
|
|
Term
Sulfas: Hypersensitivity Reactions
Frequent
(3) |
|
Definition
- *Drug Fever (3% w sulfisoxazole)
- *Skin Rashes (2%) during 1st wk
- *Photosensitivity
|
|
|
Term
Sulfas: Hypersensitivity Reactions
Occasional but Serious:
(4) |
|
Definition
- *Erythema multiforme (Stevens-Johnson syndrome): the most serious sulfa rash
- It can cause exfoliation
- It occurs very infrequently
- It can occur with any sulfa drug but occurs most often with long-acting sulfas
|
|
|
Term
Sulfas: Other Toxicities & Drug Interactions
(8) |
|
Definition
- *Hematopoietic anemia or abnormalities: occasional serious blood dyscrasias including agranulocytosis (0.1%)
- Vasculitis (opccasional)
- Hepatotoxicity (occasional; 0.1%)
- *Kernicterus (occasional)
- Displaces bilirubin from albumin
- Shouldn’t be given to near-term women
- Also, keep in mind that sulfas are secreted in milk of nursing moms
- Pregnancy: FDA Recommendation “C” but contraindicated near term
|
|
|
Term
Structure Of Trimethoprim |
|
Definition
*Used x bacteria parasites some fungi |
|
|
Term
Structure of Trimethoprim Trimethoprim |
|
Definition
|
|
Term
Structure of Trimethoprim Pyrimethamine Mechanism of TMP-SMX
(2) |
|
Definition
- *TMP/PMA [trimethoprim or pyrimethamine] competitively inhibits DHFR by binding to the active site for dihydrofolic acid.
- *The simultaneous presence of SMX in TMP/SMX *potentiates action of TMP/PMA by ↓ the concentration of dihydrofolic acid.
|
|
|
Term
|
Definition
- *TMP/PMA [trimethoprim or pyrimethamine] competitively inhibits DHFR by binding to the active site for dihydrofolic acid.
- *The simultaneous presence of SMX in TMP/SMX *potentiates action of TMP/PMA by ↓ the concentration of dihydrofolic acid
|
|
|
Term
Mechanism of TMP-SMX Structure |
|
Definition
|
|
Term
Specificity of Inhibitors of Dihydrofolate |
|
Definition
Specificity of Inhibitors of Dihydrofolate |
|
|
Term
Antifolate: (3) Trimethoprim Alone
(Proloprim) |
|
Definition
x cancer, x autoimmune diseases, for induction of abortions |
|
|
Term
|
Definition
- Only marketed for oral Rx of uncomplicated UTIs caused by gm(-) bacilli.
- Can result in resistance to this drug and to trimethoprim-sulfamethoxazole.
- Resistance to TMP alone occurs by:
- Alteration of dihydrofolate reductase
- Reduced permeability
- Conversion to thymidine dependence
|
|
|
Term
Major Rx Uses of TMP-SMX General
(6) |
|
Definition
- *Med Lett drug of choice for 11 organisms including:
- Gram-negative bacilli (5)
- Actinomycetes (2)
- Parasites (3)
- One fungus (*Pneumocystis jiroveci; formerly called P. carinii )
- *An important backup drug for 17 other organisms.
|
|
|
Term
Major Rx Uses of TMP-SMX
(4) |
|
Definition
- *Oral Rx of UTIs & Prostatis
- *Bacterial Respiratory Tract Infections
- *GI Infections:
- *MRSA
|
|
|
Term
Major Rx Uses of TMP-SMX
*Oral Rx of UTIs & Prostatis
(3) |
|
Definition
- Especially useful for recurrent UTIs
- Bacterial prostatis Used as a backup to FQs
|
|
|
Term
Major Rx Uses of TMP-SMX
*Bacterial Respiratory Tract Infections
(3) |
|
Definition
- Otitis media in kids
- Sinusitis in adults
- Acute chronic bronchitis
|
|
|
Term
Major Rx Uses of TMP-SMX *GI Infections:
(4) |
|
Definition
- Shigellosis (backup to FQs)
- Traveler’s diarrhea
- Enterohemorrhagic E. coli O157:H7
- BUT Rx can ↑ risk of hemolytic–uremic syndrome
|
|
|
Term
Major Rx Uses of TMP-SMX
*MRSA
(3) |
|
Definition
- Methicillin-resistant Staph aureus (MRSA) infections
- Only used as a backup, limited experience
|
|
|
Term
Major Rx Uses of TMP-SMX
AIDs Patients Bacterial Infections
(4)
|
|
Definition
- *Treatment of choice for 3 parasitic infections especially prevalent in AIDS patients.
- *Cyclospora cayetanensis (cyclosporiasis)
- *Isospora belli diarrhea (IV) (isosporiasis)
- *Toxoplasmosis (actually pyrimethamine + sulfadiazine + leucovorin (10-25 mg with each dose of pyrimethamine))
|
|
|
Term
Major Rx Uses of TMP-SMX
AIDs Patients Fungal Infections
(3) |
|
Definition
- *Treatment of choice for one fungal infection especially common in AIDS patients
- *Pneumocystis jiroveci pneumonia (“PCP”: IV); both treatment and prophylaxis
- Listed as a parasite in the Med. Letter Handbook; formerly called P. carini
|
|
|
Term
Toxicity of TMP-SMX
General
(2) |
|
Definition
- *Drug-induced glossitis (inflam. of the tongue) and/or stomatitis (inflam. of the mucous membranes in the mouth) are not uncommon!
- BUT DRUG-INDUCED ANGIOEDEMA IS RARELY THIS BAD!
|
|
|
Term
Toxicity of TMP-SMX
Overview
(6) |
|
Definition
- *Other hypersensitivity reactions,
- *Skin problems
- *CNS
- *Crystalluria
- *Anti-folate effects
- Also includes toxicities listed for sulfonamides alone.
|
|
|
Term
Toxicity of TMP-SMX
*Other hypersensitivity reactions,
(6) |
|
Definition
- include
- fever,
- rashes,
- photosensitivity,
- leukopenia, &
- diarrhea (esp. in AIDS pts).
|
|
|
Term
Toxicity of TMP-SMX
*Skin problems
(2) |
|
Definition
- 3x more likely than with SMX alone;
- especially common in the elderly
|
|
|
Term
Toxicity of TMP-SMX
*CNS
(4) |
|
Definition
- rare:
- headache,
- depression,
- hallucinations
|
|
|
Term
Toxicity of TMP-SMX
*Crystalluria
(1) |
|
Definition
- is rare but the combo is contraindicated in pts w ⬇⬇ renal function as it can cause permanent kidney damage.
|
|
|
Term
Toxicity of TMP-SMX
*Anti-folate effects
(6) |
|
Definition
- anemia,
- leukopenia,
- thrombocytopenia
- are: blocked by
- coadministration of folinic acid without loss of antimicrobial action.
- rare unless patient is folate deficient
|
|
|
Term
Specific Therapeutic Uses Of Individual Sulfonamides
SULFISOXAZOLE (GANTRISIN): ORAL General
(3) |
|
Definition
- *The Oral Sulfonamide Of Choice
- *Very soluble in water so unlikely to cause crystalluria
*However, has the shortest t½ (ca 5-6 hr)
- Specific Therapeutic Uses Of Individual Sulfonamides
|
|
|
Term
Drug Resistance to TMP-SMX
(3) |
|
Definition
- *Resistance is less common than against a single sulfonamide
- Two genetic changes must take place.
- It can occur via plasmid transfer.
|
|
|